[HTML][HTML] The role of CD133 in cancer: a concise review

PM Glumac, AM LeBeau - Clinical and translational medicine, 2018 - Springer
Despite the abundant ongoing research efforts, cancer remains one of the most challenging
diseases to treat globally. Due to the heterogenous nature of cancer, one of the major …

Caspase‐8: A key protein of cross‐talk signal way in “PANoptosis” in cancer

M Jiang, L Qi, L Li, Y Wu, D Song… - International journal of …, 2021 - Wiley Online Library
Cysteinyl aspartate specific proteinase (Caspase)‐8 has long been considered a promoter
of apoptosis and part of the mechanism by which cytotoxic drugs kill cancer cells. With the …

Microneedle-mediated transdermal drug delivery for treating diverse skin diseases

D Yang, M Chen, Y Sun, Y Jin, C Lu, X Pan, G Quan… - Acta Biomaterialia, 2021 - Elsevier
Transdermal drug delivery is an attractive route for dermatological disease therapy because
it can directly target the lesion site on the skin, reduce adverse reactions associated with …

[HTML][HTML] Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells

H Rezayatmand, M Razmkhah… - Stem cell research & …, 2022 - Springer
Drug resistance is the main culprit of failure in cancer therapy that may lead to cancer
relapse. This resistance mostly originates from rare, but impactful presence of cancer stem …

Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance

SM Elgendy, SK Alyammahi, DW Alhamad… - Critical Reviews in …, 2020 - Elsevier
Resistance to chemotherapeutic agents remains a major challenge in the fierce battle
against cancer. Cancer stem cells (CSCs) are a small population of cells in tumors that …

Bcl-2 antiapoptotic family proteins and chemoresistance in cancer

S Maji, S Panda, SK Samal, O Shriwas, R Rath… - Advances in cancer …, 2018 - Elsevier
Cancer is a daunting global problem confronting the world's population. The most frequent
therapeutic approaches include surgery, chemotherapy, radiotherapy, and more recently …

DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG

O Shriwas, M Priyadarshini, SK Samal, R Rath… - Apoptosis, 2020 - Springer
Platinum based drugs alone or in combination with 5FU and docetaxel are common regimen
chemotherapeutics for the treatment of advanced OSCC. Chemoresistance is one of the …

[HTML][HTML] Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents

H Kikuchi, B Yuan, X Hu, M Okazaki - American journal of cancer …, 2019 - ncbi.nlm.nih.gov
Cancer is a diverse class of diseases characterized by uncontrolled cell growth with the
potential to invade and spread to other parts of the body, and continues to be one of the …

[HTML][HTML] Cancer stem cells and their possible implications in cervical cancer: a short review

R Di Fiore, S Suleiman, R Drago-Ferrante… - International journal of …, 2022 - mdpi.com
Cervical cancer (CC) is the fourth most common type of gynecological malignancy affecting
females worldwide. Most CC cases are linked to infection with high-risk human …

[HTML][HTML] Overview of cancer stem cells and stemness for community oncologists

JD Lathia, H Liu - Targeted oncology, 2017 - Springer
Advances in cancer research in the past have led to an evolving understanding of cancer
pathogenesis and the development of novel drugs that significantly improve patient …